(Q81609248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

New therapies for systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

10 January 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

F Goldblatt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

205-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15807843%20AND%20SRC:MED&resulttype=core&format=json

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

10 January 2020

cites work

1 reference

12 December 2020

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

1 reference

12 December 2020

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus

1 reference

12 December 2020

Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus

1 reference

12 December 2020

Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus

1 reference

12 December 2020

Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases

1 reference

12 December 2020

Successful mycophenolate mofetil treatment of glomerular disease

1 reference

12 December 2020

Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.

1 reference

12 December 2020

Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function

1 reference

12 December 2020

Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes

1 reference

12 December 2020

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

1 reference

12 December 2020

Renal expression of IL-6 and TNFalpha genes in lupus nephritis

1 reference

12 December 2020

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

1 reference

12 December 2020

Cyclophosphamide for the treatment of systemic lupus erythematosus

1 reference

12 December 2020

Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment

1 reference

12 December 2020

Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus

1 reference

12 December 2020

Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens

1 reference

12 December 2020

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis

1 reference

12 December 2020

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

1 reference

12 December 2020

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative

1 reference

12 December 2020

Pulse methylprednisolone in SLE.

1 reference

12 December 2020

Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis

1 reference

12 December 2020

Methylprednisolone pulse therapy for lupus nephritis: a followup study

1 reference

12 December 2020

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

12 December 2020

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

1 reference

12 December 2020

CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells

1 reference

12 December 2020

Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.

1 reference

12 December 2020

Attenuation of murine lupus nephritis by mycophenolate mofetil.

1 reference

12 December 2020

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

1 reference

12 December 2020

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

1 reference

12 December 2020

Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study

1 reference

12 December 2020

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus

1 reference

12 December 2020

Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides

1 reference

12 December 2020

Treatment of lupus nephritis: a meta-analysis of clinical trials

1 reference

12 December 2020

Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity

1 reference

12 December 2020

Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network

1 reference

12 December 2020

Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.

1 reference

12 December 2020

Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis

1 reference

12 December 2020

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

1 reference

12 December 2020

Sequential therapies for proliferative lupus nephritis

1 reference

12 December 2020

Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide

1 reference

12 December 2020

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention

1 reference

12 December 2020

Autologous stem cell transplantation for systemic lupus erythematosus

1 reference

12 December 2020

The role of CD40 ligand in systemic lupus erythematosus

1 reference

12 December 2020

IL-1RA in refractory systemic lupus erythematosus

1 reference

12 December 2020

Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells

1 reference

12 December 2020

Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines

1 reference

12 December 2020

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

1 reference

12 December 2020

Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE

1 reference

12 December 2020

Conference report--lupus nephritis: diagnosis, therapy, and outcomes

1 reference

12 December 2020

Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus

1 reference

12 December 2020

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.

1 reference

12 December 2020

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma

1 reference

12 December 2020

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

1 reference

12 December 2020

Systemic lupus erythematosus in North American Indians: a population based study

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

12 December 2020

Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus

1 reference

12 December 2020

Interleukin 10: a new therapeutic target in systemic lupus erythematosus?

1 reference

12 December 2020

Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide

1 reference

12 December 2020

Relapse of systemic lupus erythematosus.

1 reference

12 December 2020

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

12 December 2020

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

1 reference

12 December 2020

Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone

1 reference

12 December 2020

The safety and efficacy of MMF in lupus nephritis: a pilot study

1 reference

12 December 2020

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

12 December 2020

Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report

1 reference

12 December 2020

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

1 reference

12 December 2020

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

12 December 2020

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

1 reference

12 December 2020

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

12 December 2020

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients

1 reference

12 December 2020

Longterm followup of childhood lupus nephritis.

1 reference

12 December 2020

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

12 December 2020

Systematic analysis of sequences of anti-DNA antibodies--relevance to theories of origin and pathogenicity

1 reference

12 December 2020

Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology

1 reference

12 December 2020

Human B cell precursors proliferate and express CD23 after CD40 ligation

1 reference

12 December 2020

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

1 reference

12 December 2020

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

1 reference

12 December 2020

Mechanism of action of hydroxychloroquine as an antirheumatic drug

1 reference

12 December 2020

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

1 reference

12 December 2020

Treatment of lupus interstitial lung disease with intravenous cyclophosphamide

1 reference

12 December 2020

T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death

1 reference

12 December 2020

Cellular localization of inflammatory cytokines in human glomerulonephritis

1 reference

12 December 2020

Long-term i.v. Ig treatment in systemic lupus erythematosus.

1 reference

12 December 2020

Humoral immune responses in CD40 ligand-deficient mice

1 reference

12 December 2020

Cyclosporine treatment of lupus membranous nephropathy

1 reference

12 December 2020

Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

1 reference

12 December 2020

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

12 December 2020

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

1 reference

12 December 2020

Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients

1 reference

12 December 2020

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity

1 reference

12 December 2020

Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone

1 reference

12 December 2020